The Future of Response Guided Therapy for Early Breast Cancer

I think the future absolutely is going to be within neo-agvent therapy more adaptive approaches but those have to be tested. I'm pretty excited that either a combination of biomarkers and may be response by imaging may give us that early look before you get to surgery so that you can actually be more sophisticated than we are right now. You also participated in a medical crossfire on CPT, EDC's and hormone receptor positive, metastatic breast cancer. Can you expand a little bit on what your positioning was during this medical crossfire?